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INTRODUCTION 
Disseminated lung tumors can have an epithelial or 
a mesenchymal nature (infrequently divergent diffe-
rentiation creates what are called mixed tumors) and 
they have two basic components: the proliferating 
neoplastic cells and supportive stroma made up of 
preexisting or "de novo "fonned connective tissue and 
blood vessels. An inflammatory reaction in the sup-
portive stroma can be present at djfferent intenstity. 
Dissemination in the lung parenchyma may occur 
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through different patterns (Table I) that represent a 
specific anatomic distribution of neoplastic cells 
inside the secondary pulmonary lobule structures. 
The knowledge of the growth patterns in the lung 
is useful in order to understand the roentgenological 
and clinical profiles with which these neoplasms 
reveal. Taking into account the nature of neoplastic 
cells and the dissemination spread into lung pa-
renchyma different clinical-roentgenological and 
anatomical entities of disseminated lung tumors can 
be separated. 
BRONCIDOLOAL VEOLAR CELL CARCINOMA 
(BAC) (Fig 1) 
It is a subset of pulmonary adenocarcinoma "in 
which cylindric tumor cells grow upon the walls of 
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TABLE 1 
Growth patterns (anatomic distribution) of disseminated lung tumors 
Growth pattern 
*Lepidic 
*Lymphatic 
•Parenchymal consolidation 
*Nodular (with or without escavation) 
* Angiocenlric 
*Intravascular 
*Peri bronchiolar 
*Pleural/subpleural 
Examples 
Bronchioloalvcolnr carcinoma 
Lymphangitic carcinomatosis 
Lymphomas, Kaposi sarcoma 
Breast carcinoma, 
Metastases, Bronchioloalveolar cell 
Carcinoma, Lymphomas 
Lymphomas 
Lymphomas 
Lymphangitic carcinomatosis, 
Kaposi sarcoma 
Lymphangitic carcinomatosis, 
Lymphomas 
Fig. lA - HRCT: areas of alveolar and ground glass opacilication in the right lower lobe 
and in the left lobe (BAC, mucinous subtype) 
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Fig. lB - HRCT: a core of alveolar opacification surrounded by ground glass atenuntion 
and a crazy paving in the upper right lobe (BAC. nonmucinous subtype) 
Fig. 1C - HRCT: cysts wiLh a thick wall in the lung ("socalled chcrrios in the lung") 
(BAC with papillary aspects) 
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Fig. lD- SAL, Papanicolaou stained smear. A true papilla consisting of neoplastic 
epithelial cells 
Fig. 1E - BAL. Neoplastic cells are depicted by a anti PE-1 0 monoclonal antibody 
(PAP method) 
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preexisting alveoli". The growth pattern is called 
"lepidic" because the tumor cells resemble butterflies 
sitting or alighting on a fence. Neoplastic cells have 
ultrastructural and immunohistochemical features 
indicating an origin from Clara cells, bronchiolar 
goblet cells or type II pneumocytes. 
The key feature of BAC is preservation of the 
underlyjng architecture of the lung. Histologically 
BACs are separard into major subtypes: non mucinous 
consisting of cuboidal or hobnail-shaped cells and 
mucinous variant composed of taJI, uniform, columnar 
mucinous ceiJs. Most nonmucinous BACs have miJd 
interstitial thlckening and fibrosis and a mHd interstiti-
al infiltrate ofT lymphocytes and plasmacells.Electron 
microscopy and immunohistochemistry have also 
identifed Langherans cells in the interstitial infiltrate. 
When discernible "scar" can be recognized both 
grossly and microscopically the term "sclerosing 
BAC " is used. 
Mucinous BACs may be associated with a B-cell 
lymphocytic response in the form of lymphoid hyper-
plasia of BALT (bronchus associated lymphoid 
tissue). A BOOP-Iike reaction around neoplastic 
infLitration can also be observed. 
A characteristic histologic feature of BACs which 
probably correlates with aerogenous spread, is the 
presence of single cells, acinar clusters, and papillary 
groups lying free in alveolar spaces. Multifocality has 
aLso been documented and atypical adenomatous 
hyperplasia is considered a preneoplastic trasnforma-
tion. Diffuse fibrotic process such as idiopathic usual 
interstitial pneumonitis (UIP), UIP associated to 
collagen-vascular diseases, busulfan induced fibrosis, 
radiation fibrosis, lipoid pneumonia, histiocytosis X, 
Hodgkin's disease can develop diffuse BAC. Small 
nodules with histology and immunohistochemistry 
findings identical to that found in BAC but with an 
umpredictable biological behavior have been descri-
bed in young people treated wtih bleomycin for germ 
cell tumors or osteosarcoma. Numerous extrapuJmo-
nary tumors can metastatize to the lung parenchyma 
in a manner indistinguishable from a primary BAC: 
tumors from colon, breast, pancreas, stomach, ovary, 
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biliary tract, prostate, uterus, kidney, urinary bladder, 
esophagus, adrenal, larynx, smaJ bowel, skin, melano-
ma and mesothelioma.Ciinically patients with diffuse 
form of BAC present with progressive dyspnea, 
cough, bronchorrea, fatique and weight loss. Increa-
sed ESR and, rarely, eosinophilia or a leukemoid 
reaction can be observed. Prerenal azotemia, hypona-
tremia, and hypocloremia may result from bronchor-
rea.Carcinoembryonic antigen and serum CA 19-9 
may be elevated. 
HRCf rindings in BAC are singly or in combinati-
" on: diffuse, patchy or multi focal areas of alveolar 
consolidation that contain air-bronchograms or 
ground glass attenuation; ill-defined centrilobular 
nodules; diffuse small nodules mimicking the appea-
rance of hematogenous metastases. Rarely a crazy 
paving pattern or escaveted nodules ("cherrios in the 
lung") have been reported. 
The clinical-roentgenological list of disorders that 
need to be differentiated from disseminated BAC is 
reported in Table 2. 
An alveolar opacification appearing in a fibrotic 
lung need to be considerd as BAC umil the contrary 
is proven. 
Diagnosis is established by either sputum cytology 
BAL and/or transbronchiallung biopsy. 
BronchoaJveolar lavage has a high diagnostic 
yield (more than 90%) expecially in cases with an 
alveolar or ground glass attenuation on HRCT Scan. 
Clusters ofcells with three-dimensional configuration 
are the cytological counterpart of tumor papillae. The 
clear cytoplasm and a mosaic-appearance clustering 
of neoplastic cells is typical of the mucinous variant. 
The simiHty of single cancer cells to alveolar macro-
phages is sometimes very stiking, except for the 
configuration of the nuclei. 
A summary of cytologic features of BAC is listed 
in Table 3. 
From the practical point of view smears are to be 
preferred to cytospin preps because more cells are 
screened and Papanicolaou stain is the favorite 
method to use for a definitive diagnosis. 
The differential diagnosis ofBAC in BAL preps is 
Vol. VI N" 3 209 
REVISTA PORTUGUESA DE PNEUMOLOGIAJPALESTRA 
TABLE2 
List of disorders mimicking BAC 
* chronic infections 
* BOOP 
• chronic eosihophilic pneumonia (CEP) 
* pulmonary lymphomas (expecially low grade lymphocytic lymphomas) 
• alveolar proteinosis 
* lung metastases with nodular or alveolar pattern or other multi focal 
nodular tumors primary in the lung (epithelioid hemangioendothelio-
ma ... ) 
* pulmonary infarction 
• chronic thromboembolism with pulmonary hypertension 
* drug induced lung disease 
• Desquamative interstitial pneumonitis (DIP) 
* Hypersensitivity Pneumonitis (HP) 
TAULEJ 
Cytologic features of BAC in BAL preps 
* bland neoplastic cells in clusters 
* papillary fronds 
* cells with clear cytoplasm and a mosaic pattern of clustering 
* psammoma bodies (infrequent) single cells resembling alveolar macrophages 
* depth of focus (three-dimensional clusters) 
* nuclear pseudoinclusions 
* nuclei have slight degree of lobulauon 
with organizing pneumonia, pulmonary infarction, 
diffuse alveolar damage (in this cases extracellular 
amorphous cyanophilic, metacromatic, material is 
usually evident), drug induced cell damage. A good 
criterium to use is time: infact atypical ceUs are no 
more detectable in BAL fluid performed one month 
later the starting of inflammatory-reactive process. 
reported; the tumor cells were the predominant cells 
that appeared to express IL-B.The neutrophil percen-
tage in BAL fluid appeared to be an independent 
predictor of poorer outcome in patients with BAC. 
BAL fluid profile in BAC can be characterized by 
an increase of lymphocytes, neutrophHs or also 
eosinopttils. A relationship between the number of 
neuLrophils and the level of IL-8 in BAL fluid was 
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LYMPHANGITIC CARCINOMATOSIS 
As the name impUes, pulmonary lymphangitic 
carcinomawsis (LC) is characterized by metastatic 
tumor growth in the pulmonary lymphatics.Grossly 
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the lungs usually show djffuse linear and nodular 
thickening of the bronchovascu 1 ar bundles, interlobu-
lar septa, and pleural and subpleural regions, that is 
the location of pulmonary lymphatics. Submucosal 
involvement is endoscopically visible in a minority of 
cases. Hilar or mediastinal lymph nodes can be 
infiltrated by neoplastic cells. 
Microscopically tumor cells are found as plugs 
within open lymphatics, wilh variable associated 
amounts of free interstitial lumor, intraalveolar tumor 
(so-called "tumor pneumonia"), neoplastic trombi, 
edema, inflammation and desmoplastic response. The 
ceU type is usually adenocarcinoma, and the most 
common primary sites are lung, breast and gastroin-
testinal site. However the list of epithelial or me-
senchymal tumors that can metastasize to the lung 
through lymphatics is quite long (kidney, prostate, 
lung, thyroid, uterus, ovary, liver, bladder, nasop-
harynx, malignant carcinoids tumors aris~1g in the 
abdomen, melanoma, leyomiosnrcoma, mesolhclio-
ma). Clinically the syndrome is characterized by !he 
insidious onset of dyspnea and an irritating cough due 
to submucosal endobronchial lymphatic involvement. 
Rarely asmathic symtoms are present. LC produces 
restrictive ventilatory impairment, stiff noncompliant 
lungs, a reduction in the djffusing capacity for carbon 
monoxide, severe hypoxiemia. Pulmonary hypertensi-
on is observed during the clinical course. 
The radiographic manifestations of pulmonary LC 
include reticular opacilies, septal lines (Kerley B 
lines), hilar and mediastinallymphoadenopathy, and 
pleural effusion. HRCT Scan findings are more 
specific: thickening of the peribronchovascular 
interstitium surrounding vessels and bronchi in the 
parahilar lung; interlobular septal thickening and 
subpleural interstitial thickening !hat is smooth, or 
nodu Jar and "beaded"; thickening of the peribroncllo-
vascular axial imerstilium in the centri lobular zones 
and a preservation of normal lung architecture at the 
lobular level. Areas of ground glass attenuation can 
coexit for the presence of "tumoral pneumonia" or 
secondary changes (alveolar hemorrhage, BOOP). 
The distribution can be diffuse, patchy or unjlateral. 
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As many as 50 per cent cases of histologically proven 
pulmonary lymphatic carcinomatosis present with 
normal radiographs; perfusion scan may highlight 
abnormaUties in blood vessels. However HRCT Scan 
increases the diagnostic sensitivity significantly. 
The differential diagnosis of LC is Listed in Table 4. 
Bronchoscopy is the favorite diagnostic approach. 
Mucosal biopsies can be djagnostic also in cal)es in 
which submucosal is not evident. Transbronchiallung 
biopsy has a high diagnostic yield because forceps 
sample the centrilobular zone where lymphatics are 
numerous. Bronchoalveolar lavage has a diagnostic 
yield of about 80 per cent. Anapla'itic tumors can be 
hardly identified in BAL smears because neoplastic 
cells are usually not arranged in clusters and can 
easily be missed. lmmucytochemistry can be used to 
detect proteins expressed by neoplastic cells (PSA, 
tyreoglobulin, antimelanoma antibodies). 
TABLE4 
List of disorders mimicking lymphangitic carcinomatosis 
"' sarcoidosis 
• coal worker pncumocomosis 
"' silicosis 
"' pulmonary edema 
• vena-occlusive disease 
HEMATOGENOUS (NODULAR) METASTASES 
(Fig. 2) 
The lung is a particularly receptive organ because 
it recieves the entire cardiac output and a meshwork of 
capillaries may easily entrap tumor cells. Hematoge-
nous metastases typically result in multiple well-de-
fined nodules. The nodules has smooth, weel-defined 
borders and some of them may be seen to be related to 
small branches of pulmonary vessels. Cavstation can 
occur. It is most often seen in squamous cell carcmo-
ma but can be observed in adenocarcinoma or !>area-
mas. 
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Fig. 2 - 1-lRCf. nodules with a random distribution. Metastases from colon adenocarcinoma 
The relationship of metastatic nodules to lobular 
structures has been studied using HRCT, specimen 
radiographs, and stereomicroscopy by Murata et al. 
Nodules appear widely distributed throughout 
pulmonary lobules as seen on HRCT, and no predo-
minance in specific lobular regions was noted. Eleven 
per cent of small nodules appeared centrilobular, 68 
per cent were intralobular, and 21 per cent were seen 
in relation to imerlobular septa (random distribution). 
BAL has a minor role in the diagnosis of hemato-
genous metastases the sensitivity bceing less than 50 
per cent. If the nodules are cavitated or a rim of 
ground glass attenuation around the central ponion of 
the nodules is evident (and it is expression of a perip-
heral "lepidic " o "lymphangitic" growth in lung 
parenchyma) the diagnostic yield of BAL can increa-
se. 
LYMPHORETICULARTUMORS (Fig. 3) 
Lymphoreticular tumors commonly involve the 
lung particularly in patients with systemic disease or 
lymph node based lymphomas. Rarely the lung may 
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be the site of presentation and the only site initially 
involved. The clinical and roentgenological features 
of these disorders are nonspecific and the differential 
diagnosis is usually with pulmonary infections. drug 
or radiation related disorders. From the practical point 
of view four rules are being presented: 
I. the cytological spectrum of lymphornyelopro-
liferative lung disorders is large varying from 
small lymphocytic and monocytic disorders to 
large cell anaplastic lymphomas and other 
entities with cytological elements frankly 
indicating a malignant nature. 
2. with lymphoreticular infiltrates, the lymphatic 
channels are usually incospicuous, although 
the cellular infiltrates show the same distribu-
tion as the lymphatic channels (lymphatic 
distribution or "lymphatic tracking"). 
3. the monoclonal nature of the disorder can 
easily be documented in B cell lymphomas 
that have a rich neoplastic component; clonal 
population of 8 cells with lg heavy and usu-
ally light chain gene rearrangements or a 
monoclonal rearrangement of TCR is hard to 
document expecially in BAL fluid samples in 
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Fig. 3 A - HRCT': patchy, subpleural areas of ground gla~s attenuation (Low grade B 
ceJJ lymphoma of MALT type) 
Fig. 3 B - BAL. MGG smear with atypical lymphoid cells (lymphoplasmocytoid 
and centrocytic like cells) in the case of Fig. 3A) 
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Fig. 3 C - BAL. Flow cytometry analysis. A monotypic light chain restriction is evident 
(Kappa +cells: 76 per cent) 
T cell-rich B cell lymphomas or in T cell 
lymphomas. The diagnosis of Hodgkin' s 
disease relies on the evidence of typical Reed 
Sternberg cells or Hodgkin's ceiJs (if a previ-
ous diagnosis of extrapulmonary Hodgkin's 
lymphoma has been documented). 
4. BAL sensitivity and specificity is much hig-
her in lymphomas with a rich component of 
neoplastic cells and with an alveolar or 
ground glass pattern in HRCT Scan films. 
Two entities have gained special interest in chis 
group of lesions expccially because they can present 
as primary in the lung and mirnick other nonneoplas-
tic lung lesions: low grade B cell lymphomas presu-
mably derived from the MALT (Mucosa associated 
lymphoid tissue) and the so-called "Lymphomatoid 
Granulomnatosis". 
MALT lymphomas were first described by Isaac-
son and Wright in 1983 in a small series of patients 
with low-grade 8 -cell gastrointestinal lymphomas. 
Although MALT lymphomas occur most fre-
quently in the stomach they have also been reported 
in various nongastrointestinal s~tes and the lung ranks 
as one of the most involved organs outside Gltract. 
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MALT-lymphomas are characterized by neoplastic 
marginal cells (that have a centrocytic-like appearan-
ce), wich display a vruiablc combination of coloniza-
tion of reactive germinal centers, plasmacytic diffe-
rentiation, and destructive epithelial infiltration 
forming lymphoepithelial lesions. Paradoxically, 
MALT lymphomas only occasionally arise from sites 
where MALT is normally present, such as tonsil and 
Peyer's patches.The reason for this seems to be that 
MALT lymphomas generally arise in lymphoid tissue 
that has been acquired as a result of some pre-existing 
disorder, eg, Helicobacter pylori colonization in the 
stomach, follicular bronchoectasis in the lung, auto-
immune diseases (Sjogren's disease), myasthenia 
gravis and reactive or inflammatory lesions. The 
literature contains report~> of a correlation between 
hepatitis C virus infection and extranodal MALT 
lymphomas. The neoplastic cells of MALT lympho-
mas express surface and (to a lesser extent) cytoplas-
mic immun~globulin , bcl-2 protein and show light 
chain restriction. They are CD5-,CD 10- and 
Cdi9+CD20+. The bcl-2 oncogene is not rearranged 
in low grade MALT lymphomas, in contrast to follicu-
lar lymphomas. The outcome and prognosis for low 
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grade MALT lymphomas are more favorable than 
other extranodal lymphomas. 
In the lung MALT lymphomas can present with 
alveolar shadowing on HRCf Scan films or less 
frequently with areas of ground glass attenuation or 
with a nodular pattern. The diagnosis can be easily 
made with BAL in the cases with alveolar and/or 
gound glass attenuation. SAL fluid is usually charac-
terized by the presence of centrocytic-like cells or 
plasmacytic cells. Sometimes morphology is not 
characteristic and the differential diagnosis is with 
BOOP, hypersensitivity pneumonitis, drug induced 
I ung disease or other disorders with an increase of 
lymphocytes in BAL fluid. 
Flow cytometry analysis is mandatory because it 
confirms the B nature of the cells (CDI9+,CD20+) 
and frequently the light chain restriction (Kappa or 
Lambda). Some case reports have shown that in BAL 
fluid a monoclonal rearrangement of the genes coding 
for immunoglobulins can be detected by molecular 
biology techniques. 
In cases with nodular pattern the definitive diagno-
sis requires a surgical lung biopsy. Liebow and 
coworkers ftrSt described lymphomatoid granuloma-
tosis in a classic article in 1972. This entity still exists 
but ,pratically speaking, it is clinically and histogene-
tically closest to lymphomas. Lesions described as 
lymphomatoid granulomatosis (L YO), polymorphic 
reticulosis, lymphocytic benign and malignant angiitis 
and granulomatosis, and angiocentric immunoprolife-
rative lesions (AIL) are all included in the group 
called by Katzenstein and Colby AlUL YG. Early 
studies suggested AJULYG was a T-cetl proliferative 
process, although recent data suggest that some cases 
(probably the majority of them) are T-cell-rich, B-cell 
proliferations in which the B cells are infected by 
Epstein-Barr virus. Similar lesions have been reported 
in immunocompromised hosts or as post-transplant 
lymphoproliferative lesions. 
Patients with AlUL YG usualy present with 
symptoms related to lung involvement such as cough, 
chest pain, or hemoptysis or with various systemic 
complaints including fever, weight loss, and malaise 
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Extrapulmonary manifestations, expecial ly skin 
lesions and neurologic, signs, are common and 
occasionally preced the onset of lung lesions. 
Macroscopically there is nodular consolidation of 
the lung with nodules up to 10 em in diameter,often 
with central necrosis and a rim of viable tissue ... 
Microscopically the nodules and infiltrates tend to be 
centered on, or adjacent to, the structures along 
lymphatic routes. The infiltrating cells consist of a 
polymorphous mixture of mononuclear cells, inclu-
ding small lymphocytes, plasma cells, histiocytes, and 
depending on the spectrum from low grade to high 
grade, large transformed lymphoid cells. 
Radiographically, bilateral nodules are present in 
three founhs of the patients. The nodules may wax 
and wane spontaneously, and cavitation is relatively 
common. Less common patterns include diffuse 
interstitial or alveolar infiltrates, localized infiltrates 
and solitary nodules. The diagnosis is made on the 
basis of a lung surgical biopsy. BAL can be useful 
because scattered lymphoid atypical large cells can be 
seen. 
BAL can be useful and may allow to make a 
definitive diagnosis in lymph node based lymphoproli-
ferative lesions involving the lung: chronic 
lymphocytic leukemia, fo llicular B cell lymphomas, 
anaplastic large cell lymphomas and other large cell 
lymphomas, Hodgkin disease, HTL Y -l related 
lymphomas/leukemias, with a diagnostic yield variyng 
from 60-70 per cent to a low 33 per cent (Hodgkin 
disease) as reported by Poletti and coworkers. 
BALis useful also in the diagnosis of lung invol-
vement due to myeloid leukemias. 
OTHER USUALLY RARER DISSEMINATED 
LUNG TUMORS 
Primary nonepithelial lung tumors that can be 
disseminated at the onset are: Kaposi's sarcoma; 
epithelioid hemangioendothelioma (the so called 
inlravascular bronchioloalveolar tumor or IYBAT); 
sarcomas of the pulmonary arteries; minute pulmo-
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nary meningoendothelial-like nodules, multinodular 
hyperplasia of type n pnt:umocytes. BALis not useful 
for diagnostic purposes bur it can be part of the 
diagnostic steps to exclude infections or othe more 
usual entities. 
CONCLUSIONS 
Disseminated lung tumors are a relevant clinical 
problem in the era of chemotherapy salvage protocols 
and the differential diagnosis is with drug and radia-
tion induced lung toxicity, pulmonary infections in 
immunocompromised host or idiopathic infiltrative 
lung diseases. BAL is a useful diagnostic tool in this 
field. Its diagnostic sensitivity is higher in bronchiolo-
alveolar carcinoma, lymphangitic carcinomatosis; 
some lymphoproliferative lung neoplasms can be 
neatly diagnosed if morphology is coupled with flow 
cytometry analysis (Table 5). 
Clinicians can predict the diagnostic yield and 
utility of BAL if HRCT Scan findings are taken into 
account, alveolar and ground glass opacification and 
linear and nodular opacities along the lymphatics 
beeing the more favorable patterns. 
Correspondence: 
Venerino Poletti. MD, 
Ospedale Maggiore 
Largo Nigrisoli 2. 40133 Bologna (I) 
e-mail:polenirino@mail.asianeLil 
TABLES 
Diagnostic yield of BALin disseminated tumors (Poletti V, personal experience) 
Bronchioloalveolar cell carcinoma 
Lymphangitic carcinomatosis 
Nodular hematogenous metastases 
Non Hodgkin lymphomas 
Hodgkin disease 
93% 
86% 
45% 
67% (§) 
33% 
(§) In cases with alveolar and or ground glass opacifications in HRCf Scan films BAL has 
a higher diagnostic sensitivity 
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